Publications

5802 Results

Prediction Of Early Mortality With Non-Intensive Acute Myeloid Leukemia (AML) Therapies: Analysis of 1336 Patients From MRC/NCRI and SWOG

Authors
X Wang;I Thomas;C Ariti;M Dennis;P Mehta;N Russell;M Sydenham;R Hills;A Burnett;S Nand;S Assouline;L Michaelis;H Erba;K Kerr;R Walter;M Othus
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #220
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S0432, S0703, S1612

Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known

Authors
A Tarhini;A Tan;I El Naqa;S Lee;F Hodi;L Butterfield;W LaFramboise;W Storkus;J Conejo-Garcia;P Hwu;H Streicher;V Sondak;J Kirkwood
Journal / Conference
Society for Immunotherapy of Cancer’s (SITC) Annual Meeting (Nov 10-14, 2021, Washington, DC), poster
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

Females with high-risk melanoma are more likely to benefit from CTLA4 immune checkpoint inhibition with associated evidence of enhanced immune activation within the TME and the circulation

Authors
M Saad;A Tan;I El Naqa;S Lee;S Hodi;S Butterfield;W LaFramboise;W Storkus;J Conejo-Garcia;P Hwu;H Streicher;V Sondak;J Kirkwood;A Tarhini
Journal / Conference
Society for Immunotherapy of Cancer’s (SITC) Annual Meeting (Nov 10-14, 2021, Washington, DC), poster
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

S1918: A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements

Authors
E Brem;H Li;A Beaven;P Caimi;L Cerchietti;A Alizadeh;R Olin;NL Henry;H Dillon;R Little;C Laubach;M LeBlanc;J Friedberg;S Smith
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), TIPs poster, #3565
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S1918

Prognostic Factors Other than Age Drive the Risk of Disease Progression in Adults with Burkitt Lymphoma Treated with DA-EPOCH-R

Authors
R Lakhotia;K Dunleavy;J Abramson;B Powell;B Link;P Patel;P Bierman;C Melani;A Lucas;S Steinberg;JW Friedberg;B Kahl;R Little;N Bartlett;M Fanale;A Noy;W Wilson;M Roschewski
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #453
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/9177

The Evolution of Children’s Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Authors
A Lo;A Liu;Y Yasui;S Castellino;K Kelly;A Herrera;JW Friedberg;D Friedman;C Schwartz;K Roberts;L Constine;D Hodgson
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #881
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Proteogenomic Characterization of Highly Enriched Viable Leukemic Blasts in Acute Myeloid Leukemia: A SWOG Report

Authors
J Naru;M Othus;C Lin;A Moseley;A List;C Willman;E Pogosova-Agadjanyan;F Wu;F Appelbaum;H Erba;I-M Chen;I Jenkins;J Kennedy;J Delrow;J Whiteaker;J Radich;J Godwin;L Beppu;M Fitzbiggon;M Fang;P Wang;P Gafken;R Ivey;S Meshinchi;T Chauncey;T Lorentzen;U Voytovich;A Paulovich;D Stirewalt
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #522
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500

Global Proteomic Profiling Identifies Novel Prognostic Biomarkers in Undifferentiated Leukemia Blasts from Patients with NPM1 Mutations: A First-Of-Its-Kind Report Form the Fred Hutch and SWOG

Authors
D Stirewalt;M Othus;Y Naru;J Kennedy;E Pogosova-Agadjanyan;F Appelbaum;L Beppu;T Chauncey;J Delrow;H Erba;P Gafken;J Godwin;M Fitzgibbons;X Hua;I Jenkins;M Fang;R Ivey;C Lin;T Lorentzen;A Moseley;J Radich;J Voytovich;P Wang;J Whiteaker;C Willman;F Wu;S Meshinchi;A Paulovich
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #799
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500

Allogeneic transplantation in fit older adults is feasible and encouragingly efficacious. Post-remission data from the prospective ECOG-ACRIN (E2906) clinical study

Authors
Y Ofran;Z Sun;J Rowe;D Claxton;M Tallman;D Arber;A Melnick;R Levine;E Paietta;J Godwin;H Lazarus;S Luger;J Foran;M Litzow
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #413
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E2906

Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with Ibrutinib-Rituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912

Authors
P Pophali;X Wang;F Zhao;N Kay;C Hanson;M Thomas;S O'Brien;J Barrientos;E Paietta;J Leis;C Zhang;S Coutre;P Barr;A Cashen;A Mato;A Singh;R Little;H Erba;R Stone;M Litzow;M Tallman;T Shanfelt;L Wagner;L Wagner;L Wagner
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #1562
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E1912